Advertisements

Pharma cos leaning on $850,000 therapy to justify super-expensive drugs

Pharma cos leaning on $850,000 therapy to justify super-expensive drugs.....»»

Category: topSource: business-standardJan 12th, 2018

Cipla teams up with Roche Pharma to sell cancer therapy drugs in India

Cipla teams up with Roche Pharma to sell cancer therapy drugs in India.....»»

Category: featuresSource: business-standardFeb 28th, 2018

Gilead to buy Kite for promising cancer therapies in $12 bln deal

Gilead to buy Kite for promising cancer therapies in $12 bln deal.....»»

Category: global-financeSource: reutersAug 28th, 2017

Gilead to buy Kite for promising cancer therapies in $12 billion deal

Gilead to buy Kite for promising cancer therapies in $12 billion deal.....»»

Category: global-financeSource: reutersAug 28th, 2017

Johnson & Johnson profit beat fueled by strength in pharma business

Johnson & Johnson profit beat fueled by strength in pharma business.....»»

Category: global-financeSource: reutersJul 17th, 2018

US trade under a cloud, China opens to Indian pharma - Economic Times

US trade under a cloud, China opens to Indian pharma - Economic Times.....»»

Category: topSource: googlenewsJul 15th, 2018

Exclusive: With U.S. trade under a cloud, China opens to Indian pharma

Exclusive: With U.S. trade under a cloud, China opens to Indian pharma.....»»

Category: global-financeSource: reutersJul 12th, 2018

Sun Pharma says USFDA issues at Halol over, two specialty drugs may get nod - Business Standard

Sun Pharma says USFDA issues at Halol over, two specialty drugs may get nod - Business Standard.....»»

Category: topSource: googlenewsJun 12th, 2018

Pharma shares under pressure;Glenmark hits 52-week low, Sun Pharma falls 6%

Pharma shares under pressure;Glenmark hits 52-week low, Sun Pharma falls 6%.....»»

Category: topSource: business-standardMay 11th, 2018

Hold Glenmark Pharma, advises Sumit Bilgaiyan

Hold Glenmark Pharma, advises Sumit Bilgaiyan.....»»

Category: topSource: moneycontrolApr 9th, 2018

Pharma may see recovery with FY19 profit set to jump 20-22%: Report

Pharma may see recovery with FY19 profit set to jump 20-22%: Report.....»»

Category: economySource: moneycontrolApr 3rd, 2018

Pharma sector may post single-digit growth in FY18-20: Report

Pharma sector may post single-digit growth in FY18-20: Report.....»»

Category: economySource: moneycontrolApr 2nd, 2018

Sun Pharma: Generic, speciality drugs can drive medium-term earnings growth

Sun Pharma: Generic, speciality drugs can drive medium-term earnings growth.....»»

Category: featuresSource: business-standardMar 22nd, 2018

Sun Pharma gets 1st US FDA nod for plaque psoriasis drug Ilumya

Sun Pharma gets 1st US FDA nod for plaque psoriasis drug Ilumya.....»»

Category: featuresSource: livemintMar 21st, 2018

Pharma firms under scanner for selling drugs without safety trials

Pharma firms under scanner for selling drugs without safety trials.....»»

Category: economySource: livemintMar 19th, 2018

‘Pharma pricing headwinds to linger on’

‘Pharma pricing headwinds to linger on’.....»»

Category: topSource: the-hinduMar 3rd, 2018

Cipla ties up with Roche to sell two key drugs in India

Cipla ties up with Roche to sell two key drugs in India.....»»

Category: featuresSource: livemintFeb 28th, 2018

Cipla gains 1% on partnership with Roche Pharma

Cipla gains 1% on partnership with Roche Pharma.....»»

Category: topSource: moneycontrolFeb 27th, 2018

Pharma firms set to bring international drugs to India for niche therapies

Pharma firms set to bring international drugs to India for niche therapies.....»»

Category: economySource: business-standardFeb 24th, 2018

‘Devices, drugs need distinct laws

‘Devices, drugs need distinct laws.....»»

Category: topSource: the-hinduFeb 17th, 2018

Shaily Engineering Plastics Q3 – An expensive yet promising performer

Shaily Engineering Plastics Q3 – An expensive yet promising performer.....»»

Category: topSource: moneycontrolFeb 16th, 2018